Health Bulletin 11/January/2022

Published On 2022-01-11 11:56 GMT   |   Update On 2022-01-11 12:12 GMT
Advertisement

Here are Top Health stories of the day

Omicron cases increase by more than 400 in 24 hours; 28 states, UTs now affected


Scissors left inside body during surgery, Consumer court slaps urologist, cancer hospital with Rs 7.5 lakh compensation

The District Consumer Disputes Redressal Commission has recently directed a treating Urologist and a Ludhiana-based Cancer hospital to pay Rs 7.5 lakh as compensation to the family of a patient, who was diagnosed with urinary bladder cancer.

Advertisement

Consequently, the treating oncologist had conducted the operation and assured that the operation was successful and the complainant was fully cured and the patient was further advised to have cycle of chemotherapy. Accordingly, after discharge, the complainant kept visiting the treating hospital from time to time for chemotherapy which was conducted by another doctor on various dates.

For more information, check out the full story on the link below:

Scissors left Inside body during surgery, Consumer Court slaps urologist, Cancer hospital with Rs 7.5 lakh compensation


NEET PG 2021: NBE releases scorecards for AIQ candidates  

All applicant candidates for NEET PG 2021 are hereby informed that the individual scorecards with respect to AIQ admissions have been released by the National Board of Examinations (NBE).

The result scores of NEET-PG 2021 has been declared on 28.09.2021. The merit list in respect of admission to All India 50% quota MD/MS/Post Graduate Diploma Courses (2021 admission session) has now been declared and can be seen at NBE website https://www.natboard.edu.in/ 

For more information, check out the full story on the link below:

NEET PG 2021: NBE releases scorecards for AIQ candidates, Download Now 


J&J says its single dose protects against breakthrough COVID-19 for up to 6 months

Johnson & Johnson (JNJ.N) said on Thursday that a real-world study showed its single shot COVID-19 vaccine protects against breakthrough infections and hospitalizations for up to six months.

The study, sponsored by the vaccine developer, was conducted between Jan. 1 and Sept. 7 last year, before the Omicron variant was discovered. It is also yet to be peer-reviewed.

For more information, check out the full story on the link below:

J&J says its single dose protects against breakthrough COVID-19 for up to 6 months 

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News